NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

CUSIP: G6674U108

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Ordinary Shares, no par value per share
Shares outstanding
112,245,592
Total 13F shares
73,245,441
Share change
+4,149,397
Total reported value
$8,150,888,382
Put/Call ratio
98%
Price per share
$111.31
Number of holders
272
Value change
+$548,147,986
Number of buys
132
Number of sells
141

Quarterly Holders Quick Answers

What is CUSIP G6674U108?
CUSIP G6674U108 identifies NVCR - NovoCure Ltd - Ordinary Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q3 2020

As of 30 Sep 2020, NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by 272 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,245,441 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, Capital International Investors, BAILLIE GIFFORD & CO, Capital World Investors, BlackRock Inc., CREDIT SUISSE AG/, MACQUARIE GROUP LTD, Darsana Capital Partners LP, and MORGAN STANLEY. This page lists 272 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.